Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

James Dyer has worked on the following 37 EPO patent applications which have been published in the last five years:

EP10745668

HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES

IPC classification:
A61K 31/4015, A61K 31/4025, A61K 31/4155, A61K 31/416, A61K 31/4192, A61K 31/4245, A61K 31/4427, A61K 31/4439, A61P 9/00, A61P 29/00, C07D 207/06, C07D 403/06, C07D 403/14, C07D 407/14, C07D 413/06
Applicant:
Novartis AG
Agent:
James Dyer, Novartis AG
Status:
APPLICATION WITHDRAWN
EP11715682

TRIAZOLE COMPOUNDS AS KSP INHIBITORS

IPC classification:
A61K 31/55, A61P 35/00, C07D 249/08, C07D 403/12, C07D 405/12, C07D 405/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12720761

CSF-1R INHIBITORS FOR TREATMENT OF BRAIN TUMORS

IPC classification:
A61K 31/4439, A61K 45/06, A61P 35/00, C07D 417/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
PATENT GRANTED
EP12738676

TYROSINE LIGATION PROCESS

IPC classification:
A61K 39/00, A61K 39/02, A61K 47/48, A61P 31/00
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP12783308

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS

IPC classification:
A61K 31/4439, A61K 31/497, A61P 11/00, C07D 413/04, C07D 417/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12784701

3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH

IPC classification:
A61K 31/506, A61P 35/00, C07D 413/04, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/04, C07D 498/10, C07D 513/04
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13158259

Hydroxamate-based inhibitors of deacetylases b

IPC classification:
A61K 31/40, A61K 31/4025, A61P 35/00, C07D 207/08, C07D 401/06, C07D 403/06, C07D 405/06, C07D 413/06, C07D 471/04
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12783311

N-SUBSTITUTED HETEROCYCLYL CARBOXAMIDES

IPC classification:
A61K 31/415, A61K 31/4439, A61K 31/497, A61P 11/06
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13717317

OXAZOLIDIN- 2 -ONE COMPOUNDS AND USES THEREOF AS PI3KS INHIBITORS

IPC classification:
A61K 31/5377, A61P 35/00, C07D 413/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
PATENT GRANTED
EP14191369

Pyridine and pyrazine derivative for the treatment of chronic obstructive pulmonary disease

IPC classification:
A61K 31/44, A61K 31/443, A61K 31/4439, A61K 31/444, A61K 31/4545, A61K 31/4965, A61K 31/497, A61K 31/5377, A61P 11/12
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
PATENT GRANTED
EP13730653

BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1

IPC classification:
A61K 31/4439, A61K 31/444, A61K 31/506, A61K 31/551, A61P 35/00, C07D 401/04, C07D 401/10, C07D 401/14, C07D 403/10, C07D 405/14, C07D 413/10, C07D 413/14, C07D 471/04, C07D 487/04, C07D 487/10, C07D 491/10, C07D 498/08
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13730652

BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1

IPC classification:
A61K 31/4439, A61P 35/00, C07D 213/82, C07D 401/04, C07D 401/14, C07D 403/10
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13730655

BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1

IPC classification:
A61K 31/4439, A61K 31/444, A61K 31/496, A61K 31/5377, A61P 31/00, C07D 401/04, C07D 401/14, C07D 403/10, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/10, C07D 417/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13731958

NOVEL RING-SUBSTITUTED N-PYRIDINYL AMIDES AS KINASE INHIBITORS

IPC classification:
A61P 35/00, C07D 401/12, C07D 401/14, C07D 403/12, C07D 403/14, C07D 407/14, C07D 409/14, C07D 417/12, C07D 417/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP11728247

HETEROARYL COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

IPC classification:
A61K 31/506, A61P 35/00, C07D 417/04
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13771007

DIHYDROPYRROLIDINO-PYRIMIDINES AS KINASE INHIBITORS

IPC classification:
A61K 31/519, A61P 35/00, C07D 207/36, C07D 487/04
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
PATENT GRANTED
EP13730654

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1

IPC classification:
A61K 31/505, C07D 213/81, C07D 213/85, C07D 231/12, C07D 233/38, C07D 233/54, C07D 239/26, C07D 239/30, C07D 239/34, C07D 241/12, C07D 241/20, C07D 277/20, C07D 317/60, C07D 401/04, C07D 407/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
The patent has been granted
EP13795980

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES

IPC classification:
A61K 31/4985, A61P 33/06, C07D 487/04
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11793365

3-(AMINOARYL)-PYRIDINE COMPOUNDS

IPC classification:
A61K 31/44, A61P 35/00, C07D 213/74
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13802452

METHODS FOR MAKING CONJUGATES FROM DISULFIDE-CONTAINING PROTEINS

IPC classification:
A61K 47/48
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13795977

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES

IPC classification:
A61K 31/437, A61P 33/06, C07D 471/04
Applicant:
Novartis AG
Agent:
James Dyer, Novartis AG
Status:
EXAMINATION IN PROGRESS
EP13826625

TRICYCLIC COMPOUNDS FOR INHIBITING THE CFTR CHANNEL

IPC classification:
A61K 31/519, A61P 1/12, A61P 13/12, C07D 487/04, C07D 487/14, C07D 495/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
PATENT GRANTED
EP13826624

TRICYCLIC COMPOUNDS AS CFTR INHIBITORS

IPC classification:
A61K 31/519, A61K 31/5383, A61P 1/12, C07D 487/14, C07D 498/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
The patent has been granted
EP13818112

ARYL-SUBSTITUTED FUSED BICYCLIC PYRIDAZINE COMPOUNDS

IPC classification:
A61K 31/495, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
APPLICATION REFUSED
EP14714134

BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS

IPC classification:
C07D 213/74, C07D 213/75, C07D 233/88, C07D 237/20, C07D 239/42, C07D 241/20, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/12, C07D 405/04, C07D 405/12, C07D 405/14, C07D 413/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
The patent has been granted
EP14720357

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES

IPC classification:
A61K 31/519, A61P 33/02, C07D 487/04, C07D 491/08, C07D 491/107
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14723916

CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF

IPC classification:
A61K 47/48, A61P 35/00, C07D 233/64, C07D 249/10, C07D 401/12, C07D 405/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14716934

3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH

IPC classification:
A61K 31/506, A61P 35/00, C07D 413/04, C07D 413/14, C07D 417/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
The patent has been granted
EP14712785

3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH

IPC classification:
A61K 31/506, A61P 35/00, C07D 413/04, C07D 413/14, C07D 417/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14800191

AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

IPC classification:
A61K 31/4418, A61P 35/00, C07D 213/73, C07D 241/20, C07D 401/04, C07D 401/06, C07D 401/12, C07D 403/06, C07D 405/04, C07D 405/14, C07D 409/04, C07D 413/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP11708490

PYRIDINE AND PYRAZINE DERIVATIVE FOR THE TREATMENT OF CF

IPC classification:
A61K 31/443, A61P 11/12, C07D 213/81, C07D 241/28, C07D 401/04, C07D 403/04, C07D 405/12, C07D 413/04, C07D 413/12
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14815051

METHODS FOR OXIME CONJUGATION TO KETONE-MODIFIED POLYPEPTIDES

IPC classification:
A61K 47/48
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP11757294

TRIAZINE-OXADIAZOLES

IPC classification:
A61K 31/53, A61P 29/00, C07D 413/04, C07D 413/14, C07D 417/14, C07D 451/02, C07D 487/04, C07D 491/10, C07D 498/08
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14825046

[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS PROTOZOAN PROTEASOME INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASES SUCH AS LEISHMANIASIS

IPC classification:
A61K 31/519, A61P 33/02, C07D 487/04
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP11704225

DEUTERATED PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6

IPC classification:
A61K 31/519, A61P 35/00, C07B 59/00, C07D 487/04
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15750138

PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE

IPC classification:
A61K 31/506, A61P 31/04, C07D 401/14, C07D 413/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15766662

COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS

IPC classification:
A61K 31/44, A61K 31/4439, A61K 31/444, A61K 31/5377, A61P 35/00, C07D 213/74, C07D 401/04, C07D 401/10, C07D 401/14, C07D 407/14, C07D 411/14, C07D 413/12, C07D 413/14
Applicant:
Novartis AG
Agent:
James Dyer, Novartis Pharma AG
Status:
Request for examination was made

Please Sign in to use this feature